- Home
- UPXI vs CCAP Comparison
UPXI vs CCAP Comparison
Compare UPXI & CCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPXI
- CCAP
- Stock Information
- Founded
- UPXI 2018
- CCAP 2015
- Country
- UPXI United States
- CCAP United States
- Employees
- UPXI N/A
- CCAP N/A
- Industry
- UPXI Medicinal Chemicals and Botanical Products
- CCAP Finance: Consumer Services
- Sector
- UPXI Health Care
- CCAP Finance
- Exchange
- UPXI Nasdaq
- CCAP Nasdaq
- Market Cap
- UPXI 481.8M
- CCAP 562.2M
- IPO Year
- UPXI 2021
- CCAP N/A
- Fundamental
- Price
- UPXI $5.61
- CCAP $13.51
- Analyst Decision
- UPXI
- CCAP Buy
- Analyst Count
- UPXI 0
- CCAP 4
- Target Price
- UPXI N/A
- CCAP $16.38
- AVG Volume (30 Days)
- UPXI 5.2M
- CCAP 229.0K
- Earning Date
- UPXI 09-24-2025
- CCAP 11-10-2025
- Dividend Yield
- UPXI N/A
- CCAP 13.70%
- EPS Growth
- UPXI N/A
- CCAP N/A
- EPS
- UPXI N/A
- CCAP 1.19
- Revenue
- UPXI $15,811,345.00
- CCAP $183,172,000.00
- Revenue This Year
- UPXI $145.75
- CCAP N/A
- Revenue Next Year
- UPXI N/A
- CCAP $1.43
- P/E Ratio
- UPXI N/A
- CCAP $11.37
- Revenue Growth
- UPXI N/A
- CCAP N/A
- 52 Week Low
- UPXI $1.90
- CCAP $13.31
- 52 Week High
- UPXI $22.57
- CCAP $20.19
- Technical
- Relative Strength Index (RSI)
- UPXI 40.90
- CCAP 31.11
- Support Level
- UPXI $5.81
- CCAP $13.34
- Resistance Level
- UPXI $6.50
- CCAP $14.24
- Average True Range (ATR)
- UPXI 0.63
- CCAP 0.36
- MACD
- UPXI -0.09
- CCAP -0.06
- Stochastic Oscillator
- UPXI 13.71
- CCAP 9.19
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via a Solana treasury strategy.
About CCAP Crescent Capital BDC Inc. Common stock
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.